The prospective pioglitazone clinical trial in macrovascular events (PROactive): can pioglitazone reduce cardiovascular events in diabetes? Study design and baseline characteristics of 5238 patients (Q34329426)
scientific article
Language:
(P31) (Q13442814)
(P304) 1647-1653
(P407) (Q1860)
(P433) 7
(P478) 27
(P577) Thursday, July 1, 2004
(P921) (Q181600)
(P1433) (Q5270111)
(P1476) "The prospective pioglitazone clinical trial in macrovascular events (PROactive): can pioglitazone reduce cardiovascular events in diabetes? Study design and baseline characteristics of 5238 patients" (language: en)
(P2093) Bernard Charbonnel
John Dormandy
Erland Erdmann
Massimo Massi-Benedetti
Allan Skene
PROactive Study Group
other details
description scientific article

External Links